Regulation of gelatinase B in human monocytic and endothelial cells by PECAM-1 ligation and its modulation by interferon-beta

Journal of Leukocyte Biology

Volumn 71, Issue 1, 2002, Pages 89-98

  Nelissen, Inge ^a   Ronsse, Isabelle ^a   Van Damme, Jo ^a   Opdenakker, Ghislain ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Cell cell interaction; HUVEC; Inflammation; Matrix metalloproteinase 9; Multiple sclerosis; THP 1

Indexed keywords

BETA INTERFERON; CD31 ANTIGEN; ENZYME PRECURSOR; GAMMA INTERFERON; GELATINASE A; GELATINASE B; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; PROGELATINASE B; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME REGULATION; ENZYME RELEASE; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; INFLAMMATION; LIGATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN;

EID: 0036141220     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.71.1.89     Document Type: Article

References (51)

1. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system
2. The molecular basis of leukocytosis
3. Cytokine-regulated proteases in autoimmune diseases
4. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions
5. The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: Comparison of stages in lesion evolution
6. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders
7. Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases
8. Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study
9. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9)
10. Gelatinase B modulates selective opening of the blood-brain barrier during inflammation
11. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein
12. Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis
13. Regulation of gelatinases in microglia and astrocyte cell cultures by plant lectins
14. Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis
15. Regulation of gelatinase B (MMP-9) in leukocytes by plant lectins
16. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8
17. Natural human monocyte gelatinase and its inhibitor
18. Human hepatoma cells produce an 85 kDa gelatinase regulated by phorbol 12-myristate 13-acetate
19. Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression
20. Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production
21. Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: Implication of ICAM-1
22. Ligation of selectin L and integrin CD11b/CD18 (Mac-1) induces release of gelatinase B (MMP-9) from human neutrophils
23. The biology of PECAM-1
24. The molecular pathogenesis of multiple sclerosis
25. Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions
26. PECAM-1 (CD31) expression in the central nervous system and its role in experimental allergic encephalomyelitis in the rat
27. Interferon beta-1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase-9
28. Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosis
29. Correlation between interferon production and clinical disease activity in patients with multiple sclerosis
30. The role of interferon-beta 1 and the 26-kDa protein (interferon-beta 2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor
31. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact
32. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages
33. Human elongation factor 1 alpha: A polymorphic and conserved multigene family with multiple chromosomal localizations
34. PECAM-1 is required for transendothelial migration of leukocytes
35. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP)
36. The cytokine-protease connection: Identification of a 96-kD THP-1 gelatinase and regulation by interleukin-1 and cytokine inducers
37. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration
38. Changes in expression of the cell adhesion molecule PECAM-1 (CD31) during differentiation of human leukemic cell lines
39. Characterization of a novel myeloid antigen regulated during differentiation of monocytic cells
40. Cloning of the human platelet endothelial cell adhesion molecule-1 promoter and its tissue-specific expression. Structural and functional characterization
41. Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-alpha and IFN-gamma
42. Interferon gamma regulates platelet endothelial cell adhesion molecule 1 expression and neutrophil infiltration into herpes simplex virus-infected mouse corneas
43. Modulation of PECAM-1 (CD31) expression in human endothelial cells: Effect of IFNgamma and IL-10
44. Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: A protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase
45. Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9
46. Interferon-beta inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer
47. Multiple sclerosis: Pro- and anti-inflammatory cytokines and metalloproteinases are affected differentially by treatment with IFN-beta
48. Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS
49. T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: Implications for tubule formation
50. Association study of a new polymorphism in the PECAM-1 gene in multiple sclerosis
51. PECAM1, MPO and PRKAR1A at chromosome 17q21-q24 and susceptibility for multiple sclerosis is Sweden and Sardinia